BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18440181)

  • 21. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.
    Treesak C; Kasemsup V; Treat-Jacobson D; Nyman JA; Hirsch AT
    Vasc Med; 2004 Nov; 9(4):279-85. PubMed ID: 15678620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D; Bronas UG; Leon AS
    Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease.
    Novaković M; Krevel B; Rajkovič U; Vižintin Cuderman T; Janša Trontelj K; Fras Z; Jug B
    J Vasc Surg; 2019 Jul; 70(1):148-156. PubMed ID: 30922760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials.
    Saratzis A; Paraskevopoulos I; Patel S; Donati T; Biasi L; Diamantopoulos A; Zayed H; Katsanos K
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1125-1136. PubMed ID: 31153838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community trial of home-based exercise therapy for intermittent claudication.
    Mouser MJ; Zlabek JA; Ford CL; Mathiason MA
    Vasc Med; 2009 May; 14(2):103-7. PubMed ID: 19366815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and exercise performance after aortoiliac stent placement for claudication.
    Murphy TP; Soares GM; Kim HM; Ahn SH; Haas RA
    J Vasc Interv Radiol; 2005 Jul; 16(7):947-53; quiz 954. PubMed ID: 16002502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial.
    Nordanstig J; Gelin J; Hensäter M; Taft C; Österberg K; Jivegård L
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):220-7. PubMed ID: 21397530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta-analysis.
    Klaphake S; Buettner S; Ultee KH; van Rijn MJ; Hoeks SE; Verhagen HJ
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):150-157. PubMed ID: 29327569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management.
    Bouwens E; Klaphake S; Weststrate KJ; Teijink JA; Verhagen HJ; Hoeks SE; Rouwet EV
    Vasc Med; 2019 Jun; 24(3):208-215. PubMed ID: 30795714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences following supervised exercise therapy in patients with intermittent claudication.
    Gommans LN; Scheltinga MR; van Sambeek MR; Maas AH; Bendermacher BL; Teijink JA
    J Vasc Surg; 2015 Sep; 62(3):681-8. PubMed ID: 26304482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Three Month Home Exercise Programme Augmented with Nordic Poles for Patients with Intermittent Claudication Enhances Quality of Life and Continues to Improve Walking Distance and Compliance After One Year.
    Oakley C; Spafford C; Beard JD
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):704-709. PubMed ID: 28365377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise training for intermittent claudication.
    McDermott MM
    J Vasc Surg; 2017 Nov; 66(5):1612-1620. PubMed ID: 28874320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication.
    Nordanstig J; Taft C; Hensäter M; Perlander A; Österberg K; Jivegård L
    Br J Surg; 2016 Sep; 103(10):1290-9. PubMed ID: 27220310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short interval or continuous training programs to improve walking distance for intermittent claudication: Pilot study.
    Villemur B; Thoreau V; Guinot M; Gailledrat E; Evra V; Vermorel C; Foote A; Carpentier P; Bosson JL; Pérennou D
    Ann Phys Rehabil Med; 2020 Nov; 63(6):466-473. PubMed ID: 32272287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
    Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).
    Pokharel Y; Jones PG; Graham G; Collins T; Regensteiner JG; Murphy TP; Cohen D; Spertus JA; Smolderen K
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004157. PubMed ID: 29643064
    [No Abstract]   [Full Text] [Related]  

  • 40. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.